Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Ajman Government Media Office hosts Foreign Affairs Undersecretary at THE SIGNAL with a clear message: ‘The UAE does not seek the signal – it creates it’

    November 22, 2026

    Humaid bin Ammar attends day two of Ajman Media Forum 2026 and honours participants and partners

    November 22, 2026

    Ajman Government Media Office’s THE SIGNAL forum features Saeed Al Eter on how public trust and a successful development model underpin UAE soft power in times of crisis

    November 22, 2026
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • News
    • Lifestyle
    • Sports
    • Technology
    • Travel
    Arab DispatchArab Dispatch
    • Home
    • Contact Us
    Arab DispatchArab Dispatch
    Home » Merck and Daiichi Sankyo forge $5.5 billion cancer drug alliance
    Business

    Merck and Daiichi Sankyo forge $5.5 billion cancer drug alliance

    October 21, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop three advanced cancer therapies. Depending on the success of these pioneering cell-targeted treatments, the agreement could garner up to $22 billion for Daiichi.

    Merck and Daiichi Sankyo forge $5.5 billion cancer drug alliance

    This partnership triggered a significant positive response in the stock market, with Daiichi Sankyo’s shares soaring 14.4%, their most substantial rise in over a year. Conversely, Merck’s stocks also witnessed a 1.6% uptick during morning trade.

    Daiichi Sankyo’s ambitious growth strategy projects an approximate five-fold surge in its oncology revenue, targeting at least 900 billion yen (equivalent to $6 billion) by the end of the fiscal year in March 2026. Healthcare analyst, Tina Banerjee, commented on the deal’s significance for Daiichi Sankyo, emphasizing its potential to elevate the firm’s oncology pipeline.

    The collaboration aims to advance three drugs, classified as antibody drug conjugates (ADC), currently at different clinical development stages. These ADCs, unlike traditional chemotherapy, specifically target cancer cells, minimizing harm to healthy cells.

    Sunao Manabe, Daiichi Sankyo’s CEO, highlighted the growing competition in ADC development, elucidating the firm’s strategic decision to collaborate with Merck. Both firms acknowledged the global commercial potential of the drug candidates, estimating multi-billion dollar revenues for each entity by mid-2030s.

    The partnership stipulates joint development and potential global commercialization, except in Japan, where Daiichi retains exclusive rights. Importantly, Daiichi will manage manufacturing and supply exclusively. Financial insights reveal Merck’s $4 billion upfront payment to Daiichi, with an additional $1.5 billion spread over two years. Contingent upon reaching specific sales milestones, Merck may disburse up to $16.5 billion, equating to $5.5 billion per product.

    Evan Seigerman, an analyst at BMO Capital Markets, stated that this collaboration offers Merck a strategic foothold in the ADC domain, bolstering its cancer drug portfolio, especially as patents on its top-seller, Keytruda, approach expiration. Financial ramifications for Merck include a pretax charge of $5.5 billion due to this deal, impacting its 2023 quarterly and annual results. The deal’s influence on Daiichi Sankyo’s financial outcomes will be disclosed in upcoming communications.

    Related Posts

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026

    Petrol price jump lifts South Africa inflation as SARB weighs rates

    November 18, 2026

    AfDB backs Morocco reforms and climate resilience with €434.4m

    November 14, 2026

    DP World partner ATI wins 25-year Manila port renewal

    November 13, 2026

    ADB flags $264 billion yearly ASEAN infrastructure gap

    November 12, 2026
    Editor's Pick

    Guinea declares mpox outbreak over after 42 days without cases

    November 21, 2026

    WFP seeks $12.1 billion to feed 91 million people in 2027

    November 21, 2026

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights now

    November 20, 2026

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026
    © 2026 Arab Dispatch | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.